1 min read
Amgen Inc. Hit with $50.3M Verdict for Infringement of Patented Cancer Immunotherapy Method
N
Nishica Srivastava
January 8, 2025

Amgen Inc. Hit with $50.3M Verdict for Infringement of Patented Cancer Immunotherapy Method
Lindis Biotech, Gmbh V. Amgen Inc.
Case Background
Lind
...
Continue Reading This Article
Subscribe to access this article and our entire library of legal content.
Unlimited access to all articles
Expert legal analysis and insights
Downloadable resources and templates
Tags
patent infringement
cancer treatment
patented immunotherapy regimen
willful